January 22, 2021

The Niche

Trusted stem cell blog & resources

Megan Munsie

2 min read

Today’s piece is a stem cell movers and shakers post about individuals who have gotten awards, made moves, or otherwise made news recently. In some cases I’ve included relevant embedded tweets announcing the news. In case you’re wondering, the image at right is my attempt last year to make a graphic design that reflect both movers and shakers (the salt shaker). You can see my movers and shakers piece from mid-2017 here. I once met a scientist much earlier in my career who when …Read More

2 min read

The votes are in and the community has picked its top 10 Stem Cell Person of the Year Award finalists. Both the 20 nominees and now the 10 finalists are a diverse group. The finalists include six women and four men, from five countries and four different continents. We also got votes from readers of the blog from 32 different countries spanning every continent, which is exciting. This year’s finalists are mostly scientists, but it’s a diverse group that also includes advocates and the top vote …Read More

4 min read

Nominations have closed for the 2017 Stem Cell Person of the Year Award and we have a great group of nominees. I’ve listed them below in alphabetical order, along with a bit of description of who they are, which includes in some cases the language used by the nominator(s). Where possible I’ve included a link to a helpful webpage about them. You can read more about this award here in an archive of posts about it over the years. Note that folks at stem cell clinics …Read More

4 min read

The ability of for-profit stem cell clinics to pitch unproven, risky stem cell offerings to patients may soon get much tougher in Australia. The country’s Therapeutic Goods Administration (TGA), which has some similar responsibilities there as the FDA does here in the U.S., announced planned new reforms that’ll put stem cell clinics under more scrutiny and more thorough oversight. Hopefully it’ll in many ways provide patients with more protections. While details remain to be determined, there are four major components to the TGA policy change, which …Read More

2 min read

Here are some stem cell weekend reads for your enjoyment along with various links and headlines. Some science pubs that caught my eye: Human Neural Stem Cell Biodistribution and Predicted Tumor Coverage by a Diffusible Therapeutic in a Mouse Glioma Model High-Content Screening in hPSC-Neural Progenitors Identifies Drug Candidates that Inhibit Zika Virus Infection in Fetal-like Organoids and Adult Brain Identification for Differential Localization of Putative Corneal Epithelial Stem Cells in Mouse and Human Tracing the origins of relapse in acute myeloid leukaemia to …Read More

3 min read

A committee of the International Society for Stem Cell Research (ISSCR) did one heck of a document dump yesterday on stem cell policy, releasing a whole bunch of policy recommendations on stem cells and more. The torrent from ISSCR included a 37-page policy statement itself as well as several papers in top journals including the Lancet, Science, and Nature. This output was the product of the members of a special  ISSCR Task Force, whose members I have listed at the bottom of this post. Who …Read More

1 min read

With these recommendations I’m aiming for a diverse range of content and perspectives, some of which I may not agree with, but all of which are interesting even if they are beyond research on medicine. Prostate Organoid from Stem Cells. More organoid news. Why Do Glowing Sharks Glow? Not exactly medicine, but a cool piece from Ed Yong. Damn. Inquiry into duplications reveals “multiple” image problems in tumor study in Cell Stem Cell. Comment on Proposed Framework for NIH-Wide Strategic Plan from NIGMS’ Dr. Jon Lorsch BioPolitical …Read More